Congenital TORCH Infections

A group of infections acquired in utero through transplacental transmission, conventionally grouped under the acronym TORCH: toxoplasmosis, other agents (including syphilis and varicella), rubella, cytomegalovirus, and herpes simplex virus. The last is addressed in detail under its own entry, given its distinct presentation and management.

These infections share the potential to cause significant fetal structural anomaly, growth restriction, and long-term neurodevelopmental impairment. The pattern and severity of resulting disease relate directly to the organism involved and, critically, the gestational timing of maternal infection, given the differing vulnerability of developing fetal organ systems across gestation.

Pathophysiology and specific organisms

• Congenital toxoplasmosis results from maternal Toxoplasma gondii infection during pregnancy.
• Risk of transmission increases with advancing gestational age at maternal infection, while severity of fetal disease is generally greatest with infection earlier in pregnancy.
• The most severely affected infants show the classic triad of chorioretinitis, hydrocephalus, and intracranial calcification.
• Congenital rubella syndrome results from maternal rubella infection. Risk and severity of fetal damage are greatest with infection during the first trimester.
• The classic triad is sensorineural hearing loss, congenital cataract, and congenital heart disease (particularly patent ductus arteriosus).
• Additional recognised manifestations include growth restriction and microcephaly.
• Congenital cytomegalovirus infection is the commonest congenital infection overall. It results from maternal primary or, less commonly, recurrent cytomegalovirus infection.
• The great majority of infected infants are asymptomatic at birth. A proportion, particularly following maternal primary infection, develop significant disease.
• Manifestations include sensorineural hearing loss, microcephaly, and intracranial calcification, characteristically periventricular in distribution.
• Sensorineural hearing loss is the commonest long-term consequence. It may not become apparent until later infancy or childhood, even in an infant asymptomatic at birth.
• Congenital syphilis results from transplacental transmission of Treponema pallidum. Risk of transmission and severity of disease relate to the stage of maternal infection.
• It produces a spectrum from early manifestations (including hepatosplenomegaly, skin rash, and characteristic bony changes) through to late manifestations if inadequately treated (including Hutchinson teeth and other characteristic, permanent structural changes).
• Congenital varicella syndrome results from maternal varicella infection during a specific window of early pregnancy (predominantly the first twenty weeks).
• It produces characteristic limb hypoplasia, cutaneous scarring in a dermatomal distribution, and ocular and neurological abnormality.
• It is an uncommon though serious consequence of maternal infection at this time.

• Shared features across this group of infections include fetal growth restriction, hepatosplenomegaly, thrombocytopenia with associated petechial rash, and a range of central nervous system manifestations including microcephaly and intracranial calcification.
• This reflects the broad, overlapping pattern of multi-organ involvement characteristic of transplacental infection acquired during a period of active fetal organ development.
• Each specific organism additionally produces its own characteristic pattern of manifestation.
• Ophthalmological involvement (chorioretinitis for toxoplasmosis and cytomegalovirus, cataract for rubella) and sensorineural hearing loss (particularly characteristic of both congenital rubella and cytomegalovirus infection) recur across several of these conditions.
• A substantial proportion of infected infants, particularly with cytomegalovirus and toxoplasmosis, are asymptomatic at birth.
• Significant manifestations, particularly sensorineural hearing loss and chorioretinitis, may not become apparent until later infancy or childhood.
• Structured, longer-term follow-up is therefore essential in confirmed cases, even where the infant appears entirely well in the immediate newborn period.
• A relevant maternal history, including any documented seroconversion or compatible illness during pregnancy, together with relevant antenatal screening results, provides important diagnostic context supporting appropriate clinical suspicion and evaluation.

• Diagnosis in the newborn is generally established through specific serological testing, demonstrating infant-specific IgM antibody. Maternal IgG crosses the placenta and therefore cannot itself distinguish infant from maternal infection.
• For cytomegalovirus in particular, direct viral detection by polymerase chain reaction testing of urine or saliva obtained within the first three weeks of life is used.
• This timeframe is essential to distinguish congenital from postnatally acquired infection.
• Congenital syphilis diagnosis incorporates maternal and infant serological testing, together with careful comparison of infant and maternal titres, with a rising or persistently elevated infant titre relative to the mother supporting active congenital infection.
• Full baseline evaluation of any infant with confirmed or strongly suspected congenital infection includes cranial imaging, formal ophthalmological assessment, audiological assessment, and assessment of liver function and platelet count.
• It is directly relevant to both immediate management and longer-term surveillance planning.
• Antenatal screening for rubella immunity and syphilis is a standard, routine component of antenatal care in the great majority of healthcare settings.
• Screening for toxoplasmosis and cytomegalovirus varies according to local or national protocol, given differing approaches to population-level screening for these infections.

• Congenital toxoplasmosis is treated with a combination of pyrimethamine, sulfadiazine, and folinic acid, generally continued for a prolonged course, commonly around twelve months, in confirmed symptomatic infants, aiming to reduce the severity and progression of chorioretinitis and other manifestations.
• Congenital syphilis is treated with intravenous or intramuscular penicillin, with the specific regimen and duration determined by the infant's clinical status and the adequacy of maternal treatment during pregnancy, representing effective, curative treatment when administered appropriately.
• Congenital cytomegalovirus infection with significant, symptomatic disease at birth, particularly with central nervous system involvement, is treated with valganciclovir, typically continued for six months.
• This extended duration has demonstrated improved hearing outcome.
• Treatment of asymptomatic infants remains an area of ongoing clinical consideration rather than routine, universal practice.
• Congenital rubella syndrome has no specific antiviral treatment, with management comprising full, supportive multidisciplinary care addressing the specific structural and developmental manifestations present, together with appropriate infection control precautions given the recognised, prolonged period of ongoing viral shedding and associated transmission risk from affected infants.
• Congenital varicella syndrome similarly has no specific antiviral treatment for the established structural manifestations, with management comprising full, supportive multidisciplinary care addressing the specific pattern of limb, cutaneous, ocular, and neurological involvement present in the individual infant.
• Full, structured, long-term follow-up is an essential, standard component of management across this group of conditions. It extends well beyond the immediate newborn period.
• It incorporates serial audiological and ophthalmological assessment together with developmental surveillance.
• This reflects the recognised potential for delayed manifestation of significant impairment, particularly hearing loss, in infants who may have appeared entirely asymptomatic at birth.
• Prevention is the most effective overall strategy for reducing the population burden of this group of congenital infections.
• It comprises rubella vaccination, appropriate antenatal screening and treatment of syphilis, and pregnancy-specific counselling on avoiding toxoplasmosis and cytomegalovirus exposure.
• It also includes appropriate management of maternal varicella exposure or infection during pregnancy.